ConductScience.org, home

Paper564482

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Newsom-Davis J and 3 others. Neurology, 1978. Cited by 246 papers, by iCite.

Cite this record

ConductScience Library. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Papers, record 564482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/564482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
PubMed
Journal
Neurology
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
246
iCite
Relative citation ratio, by iCite
8.13
iCite
Revised in PubMed
2019-05-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Newsom-Davis JJ
2Pinching AJA J
3Vincent AA
4Wilson SGS G

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoantibodiesMajor topic
Exchange Transfusion, Whole BloodMajor topic
Myasthenia GravisMajor topic
PlasmaMajor topic
Receptors, CholinergicMajor topic
Adult
Complement C3
Female
Humans
Immunoglobulin G
Male
Middle Aged
Muscles
Remission, Spontaneous

Source PubMed

Download CSV of topics

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.

PMIDTitleJournalYearIn PapersSource
42718778
Effects of therapeutic plasma exchange (TPE) on efficacy and adverse events in patients with autoimmune neurological diseases: a systematic review and meta-analysis based on real-world studies and single-arm clinical trials.
Front Neurol2026https://conductscience.org/library/papers/42718778PubMed
40725661
Differential Scanning Calorimetry as a Monitoring Tool for the Effectiveness of Therapeutic Plasma Exchange in Anti-AChR Myasthenia Gravis, Anti-MuSK Myasthenia Gravis, and Myasthenic Syndrome: A Case Series.
J Clin Med2025https://conductscience.org/library/papers/40725661PubMed
38780854Diagnostic value of antibody concentration ratio for treatment-refractory myasthenia gravis.Neurol Sci2024https://conductscience.org/library/papers/38780854PubMed
36270895Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.Neurology2023https://conductscience.org/library/papers/36270895PubMed
36074148Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities.Acta Neuropathol2022https://conductscience.org/library/papers/36074148PubMed
35955999Total Plasma Exchange in Neuromuscular Junction Disorders-A Single-Center, Retrospective Analysis of the Efficacy, Safety and Potential Diagnostic Properties in Doubtful Diagnosis.J Clin Med2022https://conductscience.org/library/papers/35955999PubMed
34075720No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.Brain Behav2021https://conductscience.org/library/papers/34075720PubMed
33681028Outcome of therapeutic plasma exchange in Myasthenia gravis patients.J Family Med Prim Care2020https://conductscience.org/library/papers/33681028PubMed
32843900C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis.Ther Adv Neurol Disord2020https://conductscience.org/library/papers/32843900PubMed
32028436Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis.Medicine (Baltimore)2020https://conductscience.org/library/papers/32028436PubMed
31482201Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.J Neurol2021https://conductscience.org/library/papers/31482201PubMed
28620373Mechanisms of Autoantibody-Induced Pathology.Front Immunol2017https://conductscience.org/library/papers/28620373PubMed
26977423Immunoadsorption therapy in autoimmune encephalitides.Neurol Neuroimmunol Neuroinflamm2016https://conductscience.org/library/papers/26977423PubMed
26806629Autoimmune synaptopathies.Nat Rev Neurosci2016https://conductscience.org/library/papers/26806629PubMed
25259739Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.PLoS One2014https://conductscience.org/library/papers/25259739PubMed
24675419Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli.MAbs2014https://conductscience.org/library/papers/24675419PubMed
24200120Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.J Peripher Nerv Syst2013https://conductscience.org/library/papers/24200120PubMed
23284891Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.PLoS One2012https://conductscience.org/library/papers/23284891PubMed
22882218Muscle autoantibodies in myasthenia gravis: beyond diagnosis?Expert Rev Clin Immunol2012https://conductscience.org/library/papers/22882218PubMed
20387102Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems.J Clin Immunol2010https://conductscience.org/library/papers/20387102PubMed

See all 56 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/564482

GET https://conductscience.org/api/papers/v1/564482/cited_by?page=2